Format
Items per page
Sort by

Send to:

Choose Destination

Results: 11

Related Articles by Review for PubMed (Select 21110318)

1.

IL-1β regulates a novel myeloid-derived suppressor cell subset that impairs NK cell development and function.

Elkabets M, Ribeiro VS, Dinarello CA, Ostrand-Rosenberg S, Di Santo JP, Apte RN, Vosshenrich CA.

Eur J Immunol. 2010 Dec;40(12):3347-57. doi: 10.1002/eji.201041037.

2.

Cross-talk between myeloid-derived suppressor cells (MDSC), macrophages, and dendritic cells enhances tumor-induced immune suppression.

Ostrand-Rosenberg S, Sinha P, Beury DW, Clements VK.

Semin Cancer Biol. 2012 Aug;22(4):275-81. doi: 10.1016/j.semcancer.2012.01.011. Epub 2012 Feb 1. Review.

3.

Myeloid-derived suppressor cells: linking inflammation and cancer.

Ostrand-Rosenberg S, Sinha P.

J Immunol. 2009 Apr 15;182(8):4499-506. doi: 10.4049/jimmunol.0802740. Review.

4.

Targeting immune suppressing myeloid-derived suppressor cells in oncology.

Kao J, Ko EC, Eisenstein S, Sikora AG, Fu S, Chen SH.

Crit Rev Oncol Hematol. 2011 Jan;77(1):12-9. doi: 10.1016/j.critrevonc.2010.02.004. Epub 2010 Mar 20. Review.

5.

Myeloid suppressor cells and immune modulation in lung cancer.

Srivastava MK, Andersson Å, Zhu L, Harris-White M, Lee JM, Dubinett S, Sharma S.

Immunotherapy. 2012 Mar;4(3):291-304. doi: 10.2217/imt.11.178. Review.

6.

Myeloid-derived suppressor cells: natural regulators for transplant tolerance.

Boros P, Ochando JC, Chen SH, Bromberg JS.

Hum Immunol. 2010 Nov;71(11):1061-6. doi: 10.1016/j.humimm.2010.08.001. Epub 2010 Aug 10. Review.

7.

Hampering immune suppressors: therapeutic targeting of myeloid-derived suppressor cells in cancer.

Albeituni SH, Ding C, Yan J.

Cancer J. 2013 Nov-Dec;19(6):490-501. doi: 10.1097/PPO.0000000000000006. Review.

8.

Immunotherapeutic modulation of the suppressive liver and tumor microenvironments.

Chan T, Wiltrout RH, Weiss JM.

Int Immunopharmacol. 2011 Jul;11(7):879-89. doi: 10.1016/j.intimp.2010.12.024. Epub 2011 Jan 15. Review.

9.

The role of myeloid-derived suppressor cells in immune ontogeny.

Gantt S, Gervassi A, Jaspan H, Horton H.

Front Immunol. 2014 Aug 13;5:387. doi: 10.3389/fimmu.2014.00387. eCollection 2014. Review.

10.

The biology of myeloid-derived suppressor cells: the blessing and the curse of morphological and functional heterogeneity.

Youn JI, Gabrilovich DI.

Eur J Immunol. 2010 Nov;40(11):2969-75. doi: 10.1002/eji.201040895. Review.

11.

Myeloid-derived suppressor cells as therapeutic target in hematological malignancies.

De Veirman K, Van Valckenborgh E, Lahmar Q, Geeraerts X, De Bruyne E, Menu E, Van Riet I, Vanderkerken K, Van Ginderachter JA.

Front Oncol. 2014 Dec 8;4:349. doi: 10.3389/fonc.2014.00349. eCollection 2014. Review.

Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Write to the Help Desk